AMO Joins Rapidly Growing List of MMP Portfolio Licensees

Patriot Scientific today announced that Advanced Medical Optics, Inc. (AMO) has purchased a Moore Microprocessor Patent (MMP) Portfolio license from The TPL Group, Patriot Scientific’s licensing partner. AMO is engaged in the development, manufacture and marketing of medical devices for the eye, including diagnostic instruments as well as products used in ocular surgery and laser vision correction.

“AMO is dedicated to improving the quality of vision for others through a full range of advanced refractive technologies,” said Carl Silverman, vice president of licensing for Alliacense. “We are pleased that AMO has joined the rapidly growing list of MMP Portfolio licensees.”

The sweeping scope of applications using MMP Portfolio design techniques continues to encourage the world’s leading manufacturers of end-user products from around the globe to become MMP Portfolio licensees. More than 40 global companies from the U.S., Europe, Japan, Korea and Taiwan have licensed the MMP Portfolio technologies.